Infliximab is an IgG1 murine–human antibody which has the ability to bind with high affinity and specificity to TNF-alpha, leading to important neutralizing and inhibitory activities which interfere with the inflammatory cascade in psoriasis [11]. This evidence concerns the gene TNF and psoriasis.